Regulus Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	28,495	33,425	24,929	21,606	15,028	11,942	Upgrade
Market Cap Growth	-17.83%	34.08%	15.38%	43.77%	25.85%	-22.60%	Upgrade
Enterprise Value	30,725	35,871	27,370	24,180	17,162	15,012	Upgrade
PE Ratio	9.06	8.10	6.26	16.08	8.16	10.71	Upgrade
PS Ratio	1.75	1.98	2.02	2.40	1.85	1.72	Upgrade
PB Ratio	1.45	1.66	1.50	1.79	1.26	1.04	Upgrade
P/FCF Ratio	5.46	5.23	4.84	6.13	5.05	5.13	Upgrade
P/OCF Ratio	5.42	5.19	4.79	6.05	4.99	5.06	Upgrade
EV/Sales Ratio	1.85	2.13	2.22	2.69	2.11	2.16	Upgrade
EV/EBITDA Ratio	7.31	7.65	8.22	15.93	8.55	9.82	Upgrade
EV/EBIT Ratio	7.82	8.04	8.44	17.05	8.87	10.19	Upgrade
EV/FCF Ratio	5.89	5.61	5.31	6.86	5.77	6.45	Upgrade
Debt / Equity Ratio	0.12	0.14	0.16	0.22	0.21	0.25	Upgrade
Debt / EBITDA Ratio	0.58	0.59	0.78	1.74	1.23	1.82	Upgrade
Debt / FCF Ratio	0.45	0.44	0.51	0.76	0.84	1.21	Upgrade
Quick Ratio	0.29	0.53	0.87	0.26	0.28	0.36	Upgrade
Current Ratio	0.56	1.07	1.81	0.58	0.61	0.64	Upgrade
Asset Turnover	0.27	0.27	0.26	0.21	0.21	0.21	Upgrade
Return on Equity (ROE)	17.09%	22.01%	28.41%	11.20%	16.26%	11.14%	Upgrade
Return on Assets (ROA)	3.79%	4.45%	4.19%	2.04%	3.11%	2.77%	Upgrade
Return on Capital (ROIC)	11.13%	12.85%	12.10%	5.88%	8.13%	6.90%	Upgrade
Earnings Yield	11.04%	12.46%	16.12%	6.39%	12.62%	9.62%	Upgrade
Earnings Yield	11.04%	12.46%	16.12%	6.39%	12.62%	9.62%	Upgrade
FCF Yield	18.31%	19.14%	20.67%	16.31%	19.80%	19.49%	Upgrade
Payout Ratio	51.23%	44.20%	0.90%	2.71%	2.18%	2.96%	Upgrade
Buyback Yield / Dilution	-0.37%	-0.79%	-0.32%	5.67%	2.43%	0.33%	Upgrade

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.